The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been down 1.3% at 8,235 points in afternoon trade.

Profit takers have swooped in after the bourse came within a whisker of yet another record high yesterday.

Investors have pared RBA rate cut expectations after three year bond yields spiked and traders delayed their timing of the first rate cut to May.

It’s a sea of red as all sectors are retreating. Real Estate is the worst performer, down 2.1%, followed by Health Care, down 1.9% and Discretionary, down 1.7%.

Company News

Wisetech (ASX:WTC) has been up 0.6% on news its billionaire founder Richard White has settled his legal battle with former lover Linda Rogan. Yesterday saw almost 15% and $6 billion in market cap wiped from the company’s valuation.

Wisetech has been $105.27

Magnetite Mines (ASX:MGT) has been up around 3% after joining a consortium aimed at accelerating South Australia’s green iron industry.

Magnetite Mines has been 17.5 cents.

Neometals (ASX:NMT) has confirmed Primobius, its 50/50 Joint Venture with Europe’s SMS Group, is now crucial to Mercedes Benz’s battery recycling strategy.

Neometals closed at 9.4 cents.

More From The Market Online
US flag

Dateline Resources pops +40% on Trump gov’t move to greenlight REE and gold mining

An injunction on ASX-listed Dateline Resources’ (ASX:DTR) California-based Colosseum REE and gold project appears set to be lifted after
The ASX Today feature image with a blue Australia silhouette (STOCK) beside The Market Link column branding.

ASX Today: XJO has a good day ahead of RBA rate call; AU bond sell-off continues

While we’re set to get the RBA’s next rate decision tomorrow – which all big bank analysts think is going to be a
Aussie cash

Northern Star jumps +7% on confirmed takeover rumour from Gold Fields Ltd

ASX-listed Northern Star Resources (ASX:NST) has confirmed reports in Bloomberg that it’s received a 100% takeover offer from a

AFT Pharmaceuticals opens Japan opportunity for Maxigesic IV

AFT Pharmaceuticals (ASX: AFP) has secured an exclusive development, licensing and supply agreement for its Maxigesic® IV (also known as Combogesic® IV)